» Articles » PMID: 26732615

Cost-effectiveness of Adherence-enhancing Interventions: a Systematic Review

Overview
Date 2016 Jan 7
PMID 26732615
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Low patient adherence to health-related interventions is a major barrier to achieving healthcare goals and is associated with very high avoidable costs. Although several studies suggest that adherence-enhancing interventions can improve health outcomes, economic evaluations of these interventions are scarce. Systematic reviews published to date are limited to interventions to enhance adherence to pharmaceuticals or to specific diseases and interventions. The authors' objective was to examine the evidence regarding the cost-effectiveness of adherence-enhancing interventions in healthcare and what conclusion could be drawn about these interventions. The present systematic review included 43 original studies and assessed the current evidence regarding the cost-effectiveness of a broad array of interventions aimed at enhancing adherence to medications, medical devices, screening tests and lifestyle behaviors. The authors found that although the majority of adherence-enhancing interventions were cost-effective or cost-saving, variation exists within different intervention types. Further research on the sustainability of adherence improvements is needed in order to accurately evaluate interventions' long-term benefits.

Citing Articles

Projected Cost Savings With Optimal Medication Adherence in Patients With Cardiovascular Disease Requiring Lipid-Lowering Therapy: A Multinational Economic Evaluation Study.

Cho J, Wilson F, Chaikledkaew U, Chen Y, Phrommintikul A, Diaz-Aguilera M J Am Heart Assoc. 2024; 13(22):e037792.

PMID: 39548005 PMC: 11681399. DOI: 10.1161/JAHA.124.037792.


Barriers and Unmet Educational Needs Regarding Implementation of Medication Adherence Management Across Europe: Insights from COST Action ENABLE.

Hafez G, Aarnio E, Mucherino S, Kamusheva M, Qvarnstrom M, Potocnjak I J Gen Intern Med. 2024; 39(15):2917-2926.

PMID: 38941058 PMC: 11576669. DOI: 10.1007/s11606-024-08851-2.


Drug-Related Problems Detected in Complex Chronic Patients by Community Pharmacists of Catalonia: Perception of the Person-Centred Approach Necessity.

Torres-Novellas B, Rius P, Figueiredo-Escriba C, Marino E, Modamio P Healthcare (Basel). 2024; 12(2).

PMID: 38255127 PMC: 10815887. DOI: 10.3390/healthcare12020240.


Considering patient perspectives in economic evaluations of health interventions.

Fu R, Ng V, Liu M, Wells D, Yurga E, Nauenberg E Front Public Health. 2023; 11:1212583.

PMID: 37876714 PMC: 10593459. DOI: 10.3389/fpubh.2023.1212583.


Maintaining Engagement in Adults with Neurofibromatosis Type 1 to Use the iCanCope Mobile Application (iCanCope-NF).

Buono F, Larkin K, Pham Q, De Sousa D, Zempsky W, Lalloo C Cancers (Basel). 2023; 15(12).

PMID: 37370823 PMC: 10296339. DOI: 10.3390/cancers15123213.